XORTX Therapeutics Inc

NASDAQ:XRTX  
0.48
-0.02 (-3.26%)
7:30:51 PM EDT: $0.50 +0.02 (+3.35%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

XORTX Therapeutics Inc Stock, NASDAQ:XRTX

3710�33rd Street NW, Suite 4000, Calgary, Alberta T2L 2M1
Canada
Phone: +1.403.455.7717
Number of Employees:
http://www.xortx.com

Description

XORTX Therapeutics, Inc. is a biopharmaceutical company. The firm engages in development and commercialization of innovative therapies. It focuses on drug therapies for rare orphan disease indications such as polycystic kidney disease, and the treatment of health consequences caused by chronic high serum uric acid or hyperuricemia, including Type 2 Diabetic Nephropathy, cardiovascular disease, and diabetes. The company was founded by Allen Davidoff on May 31, 2011 and is headquartered in Calgary, Canada.